Jonsson Comprehensive Cancer Center
🇺🇸United States
A Mindfulness Meditation-Based Intervention for Younger Breast Cancer Survivors
Phase 2
Completed
- Conditions
- Younger Breast Cancer Survivors
- Interventions
- Behavioral: Mindful Awareness practices (MAPs)
- First Posted Date
- 2012-03-20
- Last Posted Date
- 2015-04-10
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 71
- Registration Number
- NCT01558258
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors
Phase 2
Completed
- Conditions
- Breast Cancer
- Interventions
- Behavioral: Improving Cognition with group intervention
- First Posted Date
- 2012-02-29
- Last Posted Date
- 2015-04-10
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 48
- Registration Number
- NCT01540955
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression
- First Posted Date
- 2012-02-22
- Last Posted Date
- 2020-06-05
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 26
- Registration Number
- NCT01536743
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer
- First Posted Date
- 2012-02-14
- Last Posted Date
- 2020-09-22
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 1
- Registration Number
- NCT01532362
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Breast Cancer Screening Intervention
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Behavioral: KIM-CHIBehavioral: Healthy Wife Control Group
- First Posted Date
- 2012-02-02
- Last Posted Date
- 2016-08-18
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 434
- Registration Number
- NCT01525264
FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
Completed
- Conditions
- LymphomaLymphoma, Non-HodgkinLarge B Cell Diffuse Lymphoma
- Interventions
- Diagnostic Test: FLT-PET/CTDiagnostic Test: FDG-PET/CTDrug: FLT
- First Posted Date
- 2011-08-05
- Last Posted Date
- 2021-05-11
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 66
- Registration Number
- NCT01410630
- Locations
- 🇺🇸
University of California at Los Angeles, Los Angeles, California, United States
🇺🇸University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸MD Anderson Cancer Center - University of Texas, Houston, Texas, United States
Community Dissemination of an Evidence-based Colorectal Cancer (CRC) Screening Intervention
Not Applicable
Completed
- Conditions
- Colon CancerRectal Cancer
- Interventions
- Behavioral: Educational program and FOBT kits, and technical assistanceBehavioral: Educational program and FOBT kits
- First Posted Date
- 2011-05-10
- Last Posted Date
- 2016-08-01
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 1100
- Registration Number
- NCT01351220
- Locations
- 🇺🇸
UCLA Division of Cancer and Prevention Research, Los Angeles, California, United States
Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Not Applicable
Active, not recruiting
- Conditions
- Adenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung CancerRecurrent Non-small Cell Lung CancerSquamous Cell Lung CancerStage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
- Interventions
- Radiation: hypofractionated radiation therapyOther: laboratory biomarker analysisRadiation: image-guided radiation therapyRadiation: stereotactic body radiation therapy
- First Posted Date
- 2011-05-02
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 29
- Registration Number
- NCT01345851
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
Phase 2
Terminated
- Conditions
- Neurofibromatosis Type 2Neuroma, Acoustic
- Interventions
- First Posted Date
- 2011-04-29
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 4
- Registration Number
- NCT01345136
- Locations
- 🇺🇸
University of California Los Angeles, Los Angeles, California, United States
Dendritic Cell Vaccine for Patients With Brain Tumors
Phase 2
Completed
- Conditions
- GlioblastomaAnaplastic Astro-oligodendrogliomaGliomaAnaplastic Astrocytoma
- Interventions
- Biological: Tumor lysate-pulsed DC vaccination+0.2% resiquimodBiological: autologous tumor lysate-pulsed DC vaccinationBiological: Tumor-lysate pulsed DC vaccination +adjuvant polyICLC
- First Posted Date
- 2010-09-17
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT01204684
- Locations
- 🇺🇸
University of Los Angeles, California, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath